Altimmune Inc
Altimmune is a clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based therapeutics. The Company is developing pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of obesity and MASH.
Currently operating at a negative 244702.8% profit margin.
Current Price
$2.82
+8.46%GoodMoat Value
$0.00
99.9% overvaluedAltimmune Inc (ALT) Stock Chart
ALT Interactive Stock Chart
Interactive stock chart for Altimmune Inc (ALT) with candlestick and line chart views. Analyze price action across multiple timeframes: 5 days, 1 week, 1 month, 3 months, 6 months, 1 year, 5 years, and full history.
Current price: $2.82. 52-week high: $7.71. 52-week low: $2.60. 50-day moving average: $3.49. 200-day moving average: $4.03.
Technical analysis indicators include Volume, SMA 20, SMA 50, SMA 200, EMA 20, and RSI. Toggle between candlestick and line chart styles. Overlay multiple moving averages to identify support and resistance levels, trend direction, and momentum signals for ALT. Use the chart alongside GoodMoat's fundamental analysis tools for a complete picture of Altimmune Inc's investment potential.